Brett Sandercock - 10 Dec 2021 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Financial Officer
Signature: Brett Sandercock, Chief Financial Officer
Issuer symbol: RMD
Transactions as of: 10 Dec 2021
Net transactions value: -$517,900
Form type: 4
Filing time: 14 Dec 2021, 14:48:27 UTC
Previous filing: 18 Nov 2021
Next filing: 11 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Options Exercise	$144,400	+2,500	+2.4%	$57.76	108,854	10 Dec 2021	Direct	F1
transaction	RMD	ResMed Common Stock	Sale	$662,300	-2,500	-2.3%	$264.92	106,354	10 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Options Exercise	$0	-2,500	-11%	$0.000000	20,000	10 Dec 2021	ResMed Common Stock	2,500	$57.76	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was conducted under a Rule 10b5-1 plan.
F2	Represents date options first became exercisable. Options vest 1/3 per year.